THRESHOLD PHARMACEUTICAL INC's ticker is THLD and the CUSIP is 885807206. A total of 50 filers reported holding THRESHOLD PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $8,000 | -83.3% | 13,743 | -87.4% | 0.00% | – |
| Q4 2016 | $48,000 | -77.3% | 109,124 | -65.0% | 0.00% | – |
| Q3 2016 | $211,000 | +1072.2% | 312,134 | +703.9% | 0.00% | – |
| Q1 2016 | $18,000 | -90.3% | 38,826 | -90.0% | 0.00% | – |
| Q4 2015 | $186,000 | -85.7% | 389,100 | +21.8% | 0.00% | – |
| Q3 2015 | $1,300,000 | -91.2% | 319,528 | -91.3% | 0.00% | -100.0% |
| Q2 2015 | $14,785,000 | -15.8% | 3,659,564 | -15.4% | 0.01% | -25.0% |
| Q1 2015 | $17,561,000 | +2513.2% | 4,325,303 | +1946.8% | 0.01% | – |
| Q4 2014 | $672,000 | -54.7% | 211,316 | -48.6% | 0.00% | – |
| Q3 2014 | $1,484,000 | +51.6% | 411,132 | +66.3% | 0.00% | – |
| Q2 2014 | $979,000 | +2.6% | 247,260 | +23.4% | 0.00% | – |
| Q1 2014 | $954,000 | -34.8% | 200,377 | -36.1% | 0.00% | -100.0% |
| Q4 2013 | $1,463,000 | +282.0% | 313,467 | +280.5% | 0.00% | – |
| Q3 2013 | $383,000 | -2.8% | 82,376 | +9.9% | 0.00% | – |
| Q2 2013 | $394,000 | – | 74,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,333,490 | $847,000 | 0.43% |
| Cormorant Asset Management, LP | 1,012,255 | $643,000 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,583,160 | $1,641,000 | 0.06% |
| Alpine Global Management, LLC | 85,791 | $55,000 | 0.02% |
| Rhenman & Partners Asset Management AB | 201,537 | $128,000 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 70,000 | $44,000 | 0.01% |
| LMR Partners LLP | 80,123 | $51,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,500,000 | $2,224,000 | 0.01% |
| First Eagle Investment Management, LLC | 3,199,433 | $2,033,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 202,522 | $129,000 | 0.00% |